These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18664195)

  • 1. [Suppressive effect in vitro of resveratrol on ADP induced human platelet aggregation and its active mechanism].
    Yang YM; Wang XX; Wang SJ; Wang HQ; Chen JZ
    Yao Xue Xue Bao; 2008 Apr; 43(4):356-60. PubMed ID: 18664195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity.
    Yang YM; Wang XX; Chen JZ; Wang SJ; Hu H; Wang HQ
    Am J Chin Med; 2008; 36(3):603-13. PubMed ID: 18543392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets.
    Yang Y; Wang X; Zhang L; An H; Zao Z
    Am J Chin Med; 2011; 39(1):145-59. PubMed ID: 21213405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity.
    Yang YM; Chen JZ; Wang XX; Wang SJ; Hu H; Wang HQ
    Eur J Pharmacol; 2008 Mar; 583(1):148-55. PubMed ID: 18291361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The naphthoquinone plumbagin suppresses ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathway.
    Zhang Q; Liao X; Wu F
    Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):573-578. PubMed ID: 28650323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of activation of ADP-induced platelet aggregation under the influence of oxidatively modified fibrinogen.
    Aseichev AV; Azizova OA
    Bull Exp Biol Med; 2004 Mar; 137(3):238-41. PubMed ID: 15232628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
    Ravishankar D; Albadawi DAI; Chaggar V; Patra PH; Williams HF; Salamah M; Vaiyapuri R; Dash PR; Patel K; Watson KA; Vaiyapuri S
    Eur J Pharmacol; 2019 Nov; 862():172627. PubMed ID: 31461638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) attenuates human platelet aggregation, secretion and spreading in vitro.
    Xiang K; Liu G; Zhou YJ; Hao HZ; Yin Z; He AD; Da XW; Xiang JZ; Wang JL; Ming ZY
    Thromb Res; 2014 Feb; 133(2):211-7. PubMed ID: 24332167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet effects of a novel antianginal agent, nicorandil.
    Jaraki O; Strauss WE; Francis S; Loscalzo J; Stamler JS
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):24-30. PubMed ID: 7511731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying pathways involved in leptin-dependent aggregation of human platelets.
    Corsonello A; Malara A; De Domenico D; Perticone F; Valenti A; Buemi M; Ientile R; Corica F
    Int J Obes Relat Metab Disord; 2004 Aug; 28(8):979-84. PubMed ID: 15211358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
    Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol decreases early signaling events in washed platelets but has little effect on platelet in whole blood.
    Kirk RI; Deitch JA; Wu JM; Lerea KM
    Blood Cells Mol Dis; 2000 Apr; 26(2):144-50. PubMed ID: 11001623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban.
    Frojmovic M; Labarthe B; Legrand C
    Br J Haematol; 2005 Nov; 131(3):348-55. PubMed ID: 16225655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates.
    Marciniak SJ; Mascelli MA; Furman MI; Michelson AD; Jakubowski JA; Jordan RE; Marchese PJ; Frelinger AL
    Thromb Haemost; 2002 Jun; 87(6):1020-5. PubMed ID: 12083481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wines and grape juices as modulators of platelet aggregation in healthy human subjects.
    Pace-Asciak CR; Rounova O; Hahn SE; Diamandis EP; Goldberg DM
    Clin Chim Acta; 1996 Mar; 246(1-2):163-82. PubMed ID: 8814965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of resveratrol on platelet aggregation in vivo and in vitro.
    Wang Z; Zou J; Huang Y; Cao K; Xu Y; Wu JM
    Chin Med J (Engl); 2002 Mar; 115(3):378-80. PubMed ID: 11940369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation is inhibited by phycolectins.
    Matsubara K; Sumi H; Hori K
    Experientia; 1996 Jun; 52(6):540-3. PubMed ID: 8698085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V; Armstrong PC; Warner TD; Curzen N
    Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.